blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3183239

EP3183239 - INDAZOLES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  02.08.2019
Database last updated on 02.09.2024
FormerThe patent has been granted
Status updated on  24.08.2018
FormerGrant of patent is intended
Status updated on  24.04.2018
FormerRequest for examination was made
Status updated on  26.05.2017
FormerThe international publication has been made
Status updated on  13.01.2017
Most recent event   Tooltip01.07.2022Lapse of the patent in a contracting state
New state(s): MK
published on 03.08.2022  [2022/31]
Applicant(s)For all designated states
Merck Patent GmbH
Frankfurter Strasse 250
64293 Darmstadt / DE
For all designated states
Cancer Research Technology Ltd.
Angel Building
407 St. John Street
London EC1V 4AD / GB
[2017/26]
Inventor(s)01 / SCHIEMANN, Kai
Am Rödergraben 8
64342 Seeheim-Jugenheim / DE
02 / MALLINGER, Aurélie
6 rue du vieux Moulin
F-54800 Affleville / FR
 [2017/26]
Application number, filing date15744882.030.07.2015
[2017/26]
WO2015EP01570
Priority number, dateEP2014000292922.08.2014         Original published format: EP 14002929
[2017/26]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016026549
Date:25.02.2016
Language:EN
[2016/08]
Type: A1 Application with search report 
No.:EP3183239
Date:28.06.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 25.02.2016 takes the place of the publication of the European patent application.
[2017/26]
Type: B1 Patent specification 
No.:EP3183239
Date:26.09.2018
Language:EN
[2018/39]
Search report(s)International search report - published on:EP25.02.2016
ClassificationIPC:C07D231/56, C07D471/04, A61K31/416, A61K31/437, A61P35/00
[2017/26]
CPC:
C07D471/04 (EP,CN,IL,US); A61K31/4184 (EP,US); A61K31/437 (EP,US);
A61K31/444 (EP,US); A61K31/454 (EP,US); A61K31/4545 (EP,US);
A61K31/5377 (EP,US); A61K31/55 (EP,US); A61P25/28 (EP);
A61P29/00 (EP); A61P35/00 (EP); A61P35/02 (EP);
A61P43/00 (EP); C07D231/56 (EP,IL,US); C07D401/06 (EP,US);
C07D403/06 (EP,CN,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/26]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
TitleGerman:INDAZOLE[2017/26]
English:INDAZOLES[2017/26]
French:INDAZOLES[2017/26]
Entry into regional phase13.12.2016National basic fee paid 
13.12.2016Designation fee(s) paid 
13.12.2016Examination fee paid 
Examination procedure16.12.2016Examination requested  [2017/26]
16.12.2016Date on which the examining division has become responsible
25.04.2018Communication of intention to grant the patent
09.08.2018Fee for grant paid
09.08.2018Fee for publishing/printing paid
09.08.2018Receipt of the translation of the claim(s)
Opposition(s)27.06.2019No opposition filed within time limit [2019/36]
Fees paidRenewal fee
12.07.2017Renewal fee patent year 03
11.07.2018Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU30.07.2015
AL26.09.2018
AT26.09.2018
CY26.09.2018
CZ26.09.2018
DK26.09.2018
EE26.09.2018
FI26.09.2018
HR26.09.2018
LT26.09.2018
LV26.09.2018
MC26.09.2018
MK26.09.2018
MT26.09.2018
NL26.09.2018
PL26.09.2018
RO26.09.2018
RS26.09.2018
SE26.09.2018
SI26.09.2018
SK26.09.2018
SM26.09.2018
TR26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
IS26.01.2019
PT26.01.2019
[2022/31]
Former [2021/34]HU30.07.2015
AL26.09.2018
AT26.09.2018
CY26.09.2018
CZ26.09.2018
DK26.09.2018
EE26.09.2018
FI26.09.2018
HR26.09.2018
LT26.09.2018
LV26.09.2018
MC26.09.2018
MT26.09.2018
NL26.09.2018
PL26.09.2018
RO26.09.2018
RS26.09.2018
SE26.09.2018
SI26.09.2018
SK26.09.2018
SM26.09.2018
TR26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
IS26.01.2019
PT26.01.2019
Former [2021/32]HU30.07.2015
AL26.09.2018
AT26.09.2018
CY26.09.2018
CZ26.09.2018
DK26.09.2018
EE26.09.2018
FI26.09.2018
HR26.09.2018
LT26.09.2018
LV26.09.2018
MC26.09.2018
NL26.09.2018
PL26.09.2018
RO26.09.2018
RS26.09.2018
SE26.09.2018
SI26.09.2018
SK26.09.2018
SM26.09.2018
TR26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
IS26.01.2019
PT26.01.2019
Former [2021/26]AL26.09.2018
AT26.09.2018
CY26.09.2018
CZ26.09.2018
DK26.09.2018
EE26.09.2018
FI26.09.2018
HR26.09.2018
LT26.09.2018
LV26.09.2018
MC26.09.2018
NL26.09.2018
PL26.09.2018
RO26.09.2018
RS26.09.2018
SE26.09.2018
SI26.09.2018
SK26.09.2018
SM26.09.2018
TR26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
IS26.01.2019
PT26.01.2019
Former [2020/17]AL26.09.2018
AT26.09.2018
CZ26.09.2018
DK26.09.2018
EE26.09.2018
FI26.09.2018
HR26.09.2018
LT26.09.2018
LV26.09.2018
MC26.09.2018
NL26.09.2018
PL26.09.2018
RO26.09.2018
RS26.09.2018
SE26.09.2018
SI26.09.2018
SK26.09.2018
SM26.09.2018
TR26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
IS26.01.2019
PT26.01.2019
Former [2020/14]AL26.09.2018
AT26.09.2018
CZ26.09.2018
DK26.09.2018
EE26.09.2018
FI26.09.2018
HR26.09.2018
LT26.09.2018
LV26.09.2018
MC26.09.2018
NL26.09.2018
PL26.09.2018
RO26.09.2018
RS26.09.2018
SE26.09.2018
SI26.09.2018
SK26.09.2018
SM26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
IS26.01.2019
PT26.01.2019
Former [2019/50]AL26.09.2018
AT26.09.2018
CZ26.09.2018
DK26.09.2018
EE26.09.2018
FI26.09.2018
HR26.09.2018
LT26.09.2018
LV26.09.2018
NL26.09.2018
PL26.09.2018
RO26.09.2018
RS26.09.2018
SE26.09.2018
SI26.09.2018
SK26.09.2018
SM26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
IS26.01.2019
PT26.01.2019
Former [2019/34]AL26.09.2018
AT26.09.2018
CZ26.09.2018
DK26.09.2018
EE26.09.2018
FI26.09.2018
HR26.09.2018
LT26.09.2018
LV26.09.2018
NL26.09.2018
PL26.09.2018
RO26.09.2018
RS26.09.2018
SE26.09.2018
SK26.09.2018
SM26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
IS26.01.2019
PT26.01.2019
Former [2019/26]AL26.09.2018
AT26.09.2018
CZ26.09.2018
EE26.09.2018
FI26.09.2018
HR26.09.2018
LT26.09.2018
LV26.09.2018
NL26.09.2018
PL26.09.2018
RO26.09.2018
RS26.09.2018
SE26.09.2018
SK26.09.2018
SM26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
IS26.01.2019
PT26.01.2019
Former [2019/23]AL26.09.2018
AT26.09.2018
CZ26.09.2018
EE26.09.2018
FI26.09.2018
HR26.09.2018
LT26.09.2018
LV26.09.2018
NL26.09.2018
PL26.09.2018
RO26.09.2018
RS26.09.2018
SE26.09.2018
SK26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
IS26.01.2019
Former [2019/22]AL26.09.2018
CZ26.09.2018
FI26.09.2018
HR26.09.2018
LT26.09.2018
LV26.09.2018
NL26.09.2018
PL26.09.2018
RO26.09.2018
RS26.09.2018
SE26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
IS26.01.2019
Former [2019/21]AL26.09.2018
FI26.09.2018
HR26.09.2018
LT26.09.2018
LV26.09.2018
NL26.09.2018
RS26.09.2018
SE26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
IS26.01.2019
Former [2019/20]AL26.09.2018
FI26.09.2018
HR26.09.2018
LT26.09.2018
LV26.09.2018
NL26.09.2018
RS26.09.2018
SE26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
Former [2019/12]AL26.09.2018
FI26.09.2018
HR26.09.2018
LT26.09.2018
LV26.09.2018
RS26.09.2018
SE26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
Former [2019/11]FI26.09.2018
HR26.09.2018
LT26.09.2018
RS26.09.2018
SE26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
Former [2019/10]FI26.09.2018
LT26.09.2018
RS26.09.2018
SE26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
Former [2019/08]FI26.09.2018
LT26.09.2018
NO26.12.2018
Former [2019/07]LT26.09.2018
Cited inInternational search[A]US6107305  (MISRA RAJ N [US], et al) [A] 1-17* claims 1, 4, 23 *;
 [A]US2011034441  (HOOD JOHN [US], et al) [A] 1-17 * claims 1, 72. 75 * * page 10; table 1; compound 21 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.